Iloprost improves gas exchange in patients with pulmonary hypertension and ARDS

Chest

Volumn 144, Issue 1, 2013, Pages 55-62

  Sawheny, Eva ^a   Ellis, Ashley L ^a   Kinasewitz, Gary T ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ILOPROST;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGE DISTRIBUTION; AGED; AIRWAY PRESSURE; ARTERIAL OXYGEN TENSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; HEART RATE; HUMAN; LUNG COMPLIANCE; LUNG GAS EXCHANGE; LUNG HEMODYNAMICS; LUNG MECHANICS; LUNG VENTILATION; MALE; MEAN ARTERIAL PRESSURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 84880056825     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2296     Document Type: Article

References (37)

1. Ranieri VM, Rubenfeld GD, Thompson BT, et al; ARDS Defini tion Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012; 307 (23): 2526-2533.
2. Hudson LD, Milberg JA, Anardi D, Maunder RJ. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1995; 151 (2 pt 1): 293-301.
3. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000; 342 (18): 1301-1308.
4. Spapen H, Vincken W. Pulmonary arterial hypertension in sepsis and the adult respiratory distress syndrome. Acta Clin Belg. 1992; 47 (1): 30-41.
5. Romand JA, Donald FA, Suter PM. Cardiopulmonary interactions in acute lung injury: clinical and prognostic importance of pulmonary hypertension. New Horiz. 1994; 2 (4): 457-462.
6. Fishman AP, Fritts HW Jr, Cournand A. Effects of acute hypoxia and exercise on the pulmonary circulation. Circulation. 1960; 22: 204-215.
7. Enson Y, Giuntini C, Lewis ML, Morris TQ, Ferrer MI, Harvey RM. The influence of hydrogen ion concentration and hypoxia on the pulmonary circulation. J Clin Invest. 1964; 43: 1146-1162.
8. Greene R, Zapol WM, Snider MT, et al. Early bedside detection of pulmonary vascular occlusion during acute respiratory failure. Am Rev Respir Dis. 1981; 124 (5): 593-601.
9. Tomashefski JF Jr, Davies P, Boggis C, Greene R, Zapol WM, Reid LM. The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol. 1983; 112 (1): 112-126.
10. Snow RL, Davies P, Pontoppidan H, Zapol WM, Reid L. Pulmonary vascular remodeling in adult respiratory distress syndrome. Am Rev Respir Dis. 1982; 126 (5): 887-892.
11. Roos A, Thomas LJ Jr, Nagel EL, Prommas DC. Pulmonary vascular resistance as determined by lung inflation and vascular pressures. J Appl Physiol. 1961; 16: 77-84.
12. Hakim TS, Michel RP, Chang HK. Effect of lung inflation on pulmonary vascular resistance by arterial and venous occlusion. J Appl Physiol. 1982; 53 (5): 1110-1115.
13. Bone RC, Slotman G, Maunder R, et al. Randomized doubleblind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group. Chest. 1989; 96 (1): 114-119.
14. Kunimoto F, Arai K, Isa Y, et al. A comparative study of the vasodilator effects of prostaglandin E1 in patients with pulmonary hypertension after mitral valve replacement and with adult respiratory distress syndrome. Anesth Analg. 1997; 85( 3): 507-513.
15. Dernaika TA, Beavin ML, Kinasewitz GT. Iloprost improves gas exchange and exercise tolerance in patients with pulmo-nary hypertension and chronic obstructive pulmonary disease. Respiration. 2010; 79 (5): 377-382.
16. National Institutes of Health Clinical Center. Effect of iloprost on gas exchange and pulmonary mechanics in patients with pulmonary hypertension and ARDS/ALI. NCT01274481. ClinicalTrials.gov. Bethesda, MD: National Institutes of Health; 2010. http://clinicaltrials.gov/ct2/show/NCT01274481. Updated August 8, 2012.
17. Conrad SA, Kinasewitz GT, George RB, eds. Pulmonary Function Testing: Principles and Practice. New York, NY: Churchill Livingstone; 1984.
18. Harris KW, O'Riordan TG, Smaldone GC. Aerosolized iloprost customized for the critically ill. Respir Care. 2007; 52 (11): 1507-1509.
19. Mikawa K, Akamatsu H, Maekawa N, Nishina K, Obara H, Niwa Y. Inhibitory effect of prostaglandin E1 on human neutrophil function. Prostaglandins Leukot Essent Fatty Acids. 1994; 51 (4): 287-291.
20. Haynes DR, Whitehouse MW, Vernon-Roberts B. The prostaglandin E1 analogue, misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3. Immunology. 1992; 76 (2): 251-257.
21. Grant MM, Burnett CM, Fein AM. Effect of prostaglandin E1 infusion on leukocyte traffic and fibrosis in acute lung injury induced by bleomycin in hamsters. Crit Care Med. 1991; 19 (2): 211-217.
22. Yamanaka K, Saluja AK, Brown GE, Yamaguchi Y, Hofbauer B, Steer ML. Protective effects of prostaglandin E1 on acute lung injury of caerulein-induced acute pancreatitis in rats. Am J Physiol. 1997; 272 (1 Pt 1): G23-G30.
23. Leff JA, Baer JW, Kirkman JM, et al. Liposome-entrapped PGE1 posttreatment decreases IL-1 alpha-induced neutrophil accumulation and lung leak in rats. J Appl Physiol. 1994; 76 (1): 151-157.
24. Abraham E, Park YC, Covington P, Conrad SA, Schwartz M. Liposomal prostaglandin E1 in acute respiratory distress syndrome: a placebo-controlled, randomized, double-blind, multicenter clinical trial. Crit Care Med. 1996; 24 (1): 10-15.
25. Vincent JL, Brase R, Santman F, et al. A multi-centre, doubleblind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome. Intensive Care Med. 2001; 27 (10): 1578-1583.
26. Abraham E, Baughman R, Fletcher E, et al. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group. Crit Care Med. 1999; 27 (8): 1478-1485.
27. Radermacher P, Santak B, Wüst HJ, Tarnow J, Falke KJ. Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anesthesiology. 1990; 72 (2): 238-244.
28. Walmrath D, Schneider T, Schermuly R, Olschewski H, Grimminger F, Seeger W. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med. 1996; 153 (3): 991-996.
29. Zwissler B, Kemming G, Habler O, et al. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory dis tress syndrome. Am J Respir Crit Care Med. 1996; 154 (6 Pt 1): 1671-1677.
30. van Heerden PV, Barden A, Michalopoulos N, Bulsara MK, Roberts BL. Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS. Chest. 2000; 117 (3): 819-827.
31. Dahlem P, van Aalderen WM, de Neef M, Dijkgraaf MG, Bos AP. Randomized controlled trial of aerosolized prostacyclin therapy in children with acute lung injury. Crit Care Med. 2004; 32 (4): 1055-1060.
32. Beghetti M, Reber G, de MP, et al. Aerosolized iloprost induces a mild but sustained inhibition of platelet aggregation. Eur Respir J. 2002; 19 (3): 518-524.
33. Rossaint R, Falke KJ, López F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993; 328 (6): 399-405.
34. Michael JR, Barton RG, Saffle JR, et al. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med. 1998; 157 (5 pt 1): 1372-1380.
35. Griffiths MJ, Evans TW. Inhaled nitric oxide therapy in adults. N Engl J Med. 2005; 353 (25): 2683-2695.
36. Sittipunt C, Steinberg KP, Ruzinski JT, et al. Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001; 163( 2): 503-510.
37. Naseem KM, Riba R. Unresolved roles of platelet nitric oxide synthase. J Thromb Haemost. 2008; 6 (1): 10-19.